CORCEPT THERAPEUTICS INC (CORT)

Every figure this model derived for CORT, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 2,779,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 308,197,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 439,676,000 AssetsCurrent 2026-06-30
current liabilities 153,802,000 LiabilitiesCurrent 2026-06-30
equity 705,776,000 StockholdersEquity 2026-06-30
ocf 109,700,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 830,813,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 96,106,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up CORT on one particular measure came for.

RatioValue
cash operating margin12.54
current ratio2.86
current ratio reported2.86
deferred revenue growth-100.0
dilution pct5.74
ebit cagr-55.96
ebit yoy-93.72
fcf margin12.87
growth cv0.73
operating margin0.77
owner earnings margin1.3
revenue growth16.02
revenue growth per share9.73
roic1.27
rule of 4016.79
sbc pct revenue11.57

What to be careful about

What this model itself distrusts about CORT's figures. Written by the derivation as it ran, not added afterwards.